Jackie Joe Lindo
Nurse Practitioner · Wilmington, DENPI 1477920296
Payments from drug & device makers
Across 51 payments — averaging $30.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$216
- Dexcom, Inc.$154
- Xeris Pharmaceuticals, Inc.$122
- Regeneron$117
- Scynexis, Inc.$113
- Novo Nordisk$111
- plus $708 from 17 others
What the payments were for
- Food & beverage$1,48697%
- Education$543%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 7 | $216 |
| Dexcom, Inc. | 2 | $154 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| Regeneron | 1 | $117 |
| Scynexis, Inc. | 1 | $113 |
| Novo Nordisk | 6 | $111 |
| GSK | 3 | $98 |
| AbbVie | 5 | $83 |
| Amgen | 4 | $71 |
| Qiagen, LLC | 1 | $64 |
| Lilly USA, LLC | 3 | $61 |
| Genentech USA, Inc. | 2 | $45 |
| Boehringer Ingelheim | 2 | $44 |
| Corcept Therapeutics | 2 | $43 |
| Biohaven Pharmaceuticals, Inc. | 1 | $31 |
| Pfizer | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Abbott | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Bayer | 1 | $20 |
| Merck | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Evofem Biosciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$125
- RECORLEV$122
- DEXCOM G6 TRANSMITTER$114
How this compares
$1,540 in reported general payments places this provider in the 80th percentile of 487 nurse practitioner providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate | 11 | $1,745 |
| Quetiapine Fumarate | 22 | $1,701 |
| Mirtazapine | 35 | $1,373 |
| Donepezil Hcl | 29 | $924 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $890 |
| Levothyroxine Sodium | 66 | $787 |
| Atorvastatin Calcium | 64 | $767 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 15 | $667 |
| Ezetimibe | 13 | $622 |
| Sertraline Hcl | 32 | $614 |
| Rosuvastatin Calcium | 14 | $569 |
| Omeprazole | 31 | $560 |
| Amlodipine Besylate | 70 | $534 |
| Levetiracetam | 14 | $467 |
| Bupropion XlBupropion Hcl | 12 | $457 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Wilmington
- Colleen DitroWilmington$16K
- Jennifer HubbardWilmington$12K
- Monica SamWilmington$7K
- Brenda NardozziWilmington$7K
- Ellen NeffWilmington$5K
- Tina CubetaWilmington$5K
- Auxilia AkalaWilmington$3K
- Melissa LehrWilmington$3K
- Cathy RamageWilmington$2K
- Meghan McCarterSeaford$170K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.